1. Home
  2. CPRX vs LION Comparison

CPRX vs LION Comparison

Compare CPRX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$24.79

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$9.56

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPRX
LION
Founded
2002
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
2006
2025

Fundamental Metrics

Financial Performance
Metric
CPRX
LION
Price
$24.79
$9.56
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$35.00
$10.19
AVG Volume (30 Days)
897.2K
1.9M
Earning Date
05-06-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
28.24
N/A
EPS
1.68
N/A
Revenue
$119,072,803.00
$3,195,500,000.00
Revenue This Year
$9.20
N/A
Revenue Next Year
$10.51
$22.98
P/E Ratio
$14.75
N/A
Revenue Growth
16.39
7.00
52 Week Low
$19.05
$5.65
52 Week High
$26.56
$11.02

Technical Indicators

Market Signals
Indicator
CPRX
LION
Relative Strength Index (RSI) 58.27 52.29
Support Level $22.24 $6.46
Resistance Level $24.94 $9.64
Average True Range (ATR) 0.66 0.34
MACD 0.18 -0.05
Stochastic Oscillator 89.26 49.17

Price Performance

Historical Comparison
CPRX
LION

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: